These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29391000)

  • 1. Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2).
    Khan MF; Nahar N; Rashid RB; Chowdhury A; Rashid MA
    BMC Complement Altern Med; 2018 Feb; 18(1):48. PubMed ID: 29391000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilized betulinic acid column and its interactions with phospholipase A2 and snake venom proteins.
    Tseng HC; Liu YC
    J Sep Sci; 2004 Oct; 27(14):1215-20. PubMed ID: 15537079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics simulation and in vitro studies of betulinic acid derivative with liver X receptor.
    Yu P; Cao W; Wang Y
    J Biomol Struct Dyn; 2024 Aug; 42(13):7014-7023. PubMed ID: 37498160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation studies of betulinic acid with human serum albumin.
    Malleda C; Ahalawat N; Gokara M; Subramanyam R
    J Mol Model; 2012 Jun; 18(6):2589-97. PubMed ID: 22076062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial cyclic β-(1→3),(1→6)-glucans as potential drug carriers: Interaction studies between cyclic β-glucans isolated from Bradyrhizobium japonicum and betulinic acid.
    Kambhampati NSV; Kar S; Pinnepalli SSK; Chelli J; Doble M
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Oct; 203():494-500. PubMed ID: 29898432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into the Inhibition Mechanism of Betulinic Acid on α-Glucosidase.
    Ding H; Wu X; Pan J; Hu X; Gong D; Zhang G
    J Agric Food Chem; 2018 Jul; 66(27):7065-7075. PubMed ID: 29902001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phloroglucinol as a Potential Candidate against
    Abdulrashid NI; Aminu S; Adamu RM; Tajuddeen N; Isah MB; Jatau ID; Aliyu AB; Simelane MBC; Onyike E; Ibrahim MA
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of
    Zadeh Mehrizi T; Khamesipour A; Shafiee Ardestani M; Ebrahimi Shahmabadi H; Haji Molla Hoseini M; Mosaffa N; Ramezani A
    Int J Nanomedicine; 2019; 14():7593-7607. PubMed ID: 31802863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of antiproliferative activity of fluorinated betulinic acid.
    Li J; Chang LC; Hsieh KY; Hsu PL; Capuzzi SJ; Zhang YC; Li KP; Morris-Natschke SL; Goto M; Lee KH
    Bioorg Med Chem; 2019 Jul; 27(13):2871-2882. PubMed ID: 31126820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding Interaction of Betulinic Acid to α-Glucosidase and Its Alleviation on Postprandial Hyperglycemia.
    Chen S; Lin B; Gu J; Yong T; Gao X; Xie Y; Xiao C; Zhan JY; Wu Q
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity.
    Rajendran P; Jaggi M; Singh MK; Mukherjee R; Burman AC
    Invest New Drugs; 2008 Feb; 26(1):25-34. PubMed ID: 17851638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
    Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
    Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Betulinic Acid Analogue: Synthesis, Solubility, Antitumor Activity and Pharmacokinetic Study in Rats.
    Liang Y; Zhu M; Xu T; Ding W; Chen M; Wang Y; Zheng J
    Molecules; 2023 Jul; 28(15):. PubMed ID: 37570685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L.
    Jäger S; Winkler K; Pfüller U; Scheffler A
    Planta Med; 2007 Feb; 73(2):157-62. PubMed ID: 17415876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betulinic acid binding to human serum albumin: a study of protein conformation and binding affinity.
    Subramanyam R; Gollapudi A; Bonigala P; Chinnaboina M; Amooru DG
    J Photochem Photobiol B; 2009 Jan; 94(1):8-12. PubMed ID: 18945624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo biosynthesis of betulinic acid in engineered Saccharomyces cerevisiae.
    Tang S; Ji W; Zhao Y; Zhang J; Wei D; Wang FQ
    Bioorg Chem; 2024 Nov; 152():107737. PubMed ID: 39180862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
    Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
    Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives.
    Chowdhury AR; Mandal S; Mittra B; Sharma S; Mukhopadhyay S; Majumder HK
    Med Sci Monit; 2002 Jul; 8(7):BR254-65. PubMed ID: 12118187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, structural optimization, and anti-tumor bioactivity evaluations of betulinic acid derivatives as a new type of RORγ antagonists.
    Mei L; Xu L; Wu S; Wang Y; Xu C; Wang L; Zhang X; Yu C; Jiang H; Zhang X; Bai F; Xie C
    Eur J Med Chem; 2023 Sep; 257():115472. PubMed ID: 37236000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.